---
title: 'Postdoctoral Fellow'
timeperiod: 'Feb 2022 â€“ Feb 2025 (3 years)'
company: 'Pfizer, Cambridge, MA'
headerImage:
  light: 'public/modifier_barchart_V6.png'
  dark: 'public/modifier_barchart_invert_V6.png'
  alt: 'Bar chart illustrating the inherited threshold model of disease. The first bar shows complete penetrance in variant carriers; subsequent bars show decreasing penetrance due to common genetic modifiers.'
  caption: '<strong>Figure.</strong> <em>Inherited threshold model of disease</em>. This chart illustrates how common genetic modifiers influence the penetrance of rare monogenic diseases. The left bar shows complete penetrance: all carriers of a rare pathogenic variant (blue) are affected. The other bars represent variable penetrance, as seen in conditions like cardiomyopathies.'
publishDate: 'Feb 28 2022'
isFeatured: true
publications:
  - title: 'Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants'
    authors: 'Klasfeld, S. J., Knutson, K. A., Miller, M. R., Fauman, E. B., Berghout, J., Moccia, R., & Kim, H. I.'
    venue: 'Human Genetics and Genomics Advances'
    year: 2025
    url: 'https://www.medrxiv.org/content/10.1101/2024.12.17.24318501v1'
references:
  - label: 'UK Biobank'
    url: 'https://www.ukbiobank.ac.uk/'
  - label: 'Polygenic Risk Scores'
    url: 'https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores'
seo:
  image:
    src: 'public/modifier_barchart_V6.png'
    alt: Project preview
    width: 200
    height: 150
---

## Summary:

- Organized genetic and medical data leveraged from self-reports, electronic health records, and ~500K exomes in the [UK biobank](https://www.ukbiobank.ac.uk/) and generated version-controlled code with [git](https://git-scm.com/) to ensure reproducibility

- Leveraged latest update of [UK biobank](https://www.ukbiobank.ac.uk/) to identify a sufficiently sized cohort of known and novel cardiomyopathy variant carriers to improve upon previous studies without adequate statistical power

- Calculated [PRS](https://www.genome.gov/Health/Genomics-and-Medicine/Polygenic-risk-scores) from relevant GWAS and evaluated logistic, cox, and linear regression to quantify the association of common variants on disease penetrance, onset, and severity among the rare pathogenic variant carriers and use the results to provide
  genetic insight for decreasing disease outcomes

- Articulated technical genetic study in internal symposiums to showcase my work to multidisciplinary audiences including nonsubject
  matter experts (eg. biologists, leadership)

## Presentations

- **Klasfeld, S.**, Fauman, E.B., Miller, M.R., Moccia, R., & Kim, H.I. (2024, November 5). Coding cis pQTLs from proteogenomic data
  allow evaluation of the performance of missense variant effect predictions and the utility of their application to rare variant
  association analyses. [Poster]. American Society of Human Genetics, Denver, CO.

- **Klasfeld, S.**, Moccia, R., Knutson, A., Berghout, J., & Kim, H.I. (2023, November 1). Common genetic modifiers influence disease
  risk in carriers of rare pathogenic cardiomyopathy variants [Poster]. Pfizer Worldwide Research, Development and Medical Postdoc
  Symposium, Cambridge, MA.

- **Klasfeld, S.**, Moccia, R., Knutson, A., Berghout, J., & Kim, H.I. (2023, November 2). Genetic modifiers illuminate clinical phenotype
  penetrance in carriers of rare cardiomyopathy-causal variants [PowerPoint slides]. Pfizer Worldwide Research, Development and
  Medical Postdoc Symposium, Cambridge, MA.

- **Klasfeld, S.**, Moccia, R., & Berghout, J. (2022, November 2). Genetic modifiers illuminate frequency and penetrance of clinical and
  subclinical phenotypes in carriers of rare cardiomyopathy-causal variants [Poster]. Pfizer Worldwide Research, Development and
  Medical Postdoc Symposium, Cambridge, MA.
